Tuesday, April 01, 2025 | 07:28 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Centre says Maha in the beginning of 2nd wave

Health insurance coverage jumped in months after pandemic hit, why increased use of hand sanitisers may be bad news in the long term, and more-news relevant to India's fight against Covid-19

Mumbai
Premium

Senior citizens wait to receive a dose of COVID-19 vaccine, during the second phase of a countrywide inoculation drive, at BKC in Mumbai

Bharath Manjesh New Delhi
A look at the J&J vaccine to be produced by Hyderabad's Biological E

Hyderabad-based drugmaker Biological is set to produce Covid-19 vaccines developed in the US including the Johnson & Johnson candidate. A report in ThePrint provides a closer look at the vaccine. The inoculant is a single-dose vaccine, unlike most others such as the Pfizer and Moderna shots that need two doses. While the Pfizer and Moderna products are mRNA vaccines, the J&J shot is an adenovirus vector vaccine that works on a principle similar to mRNA but uses a different virus. A big advantage for the J&J shot is

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in